Cerebrovascular Disease: Update on Diagnosis and Treatment

Dear Colleagues,

Cerebrovascular disease (CVD) encompasses a range of disorders affecting the blood vessels in the brain, leading to significant morbidity and mortality worldwide. Conditions such as stroke, transient ischemic attack (TIA), and vascular dementia represent major public health challenges. Accurate diagnosis and timely intervention are critical to improving patient outcomes and minimizing long-term disability. As our understanding of the pathophysiology of cerebrovascular diseases evolves, so too do the diagnostic and therapeutic approaches. This Special Issue aims to provide a comprehensive update on the latest advancements in the diagnosis and treatment of cerebrovascular disease, addressing both established and emerging strategies.

The primary aim of this Special Issue is to gather and disseminate cutting-edge research and clinical insights into the diagnosis and management of cerebrovascular diseases. We seek to explore innovative diagnostic modalities, including advanced imaging techniques and biomarkers, as well as new therapeutic interventions, such as novel pharmacological agents and interdisciplinary management approaches. The scope of this issue includes, but is not limited to, studies on acute stroke management, secondary prevention strategies, rehabilitation techniques, and the integration of technology in patient care. By providing a platform for the latest research, we hope to enhance clinical practice and inform future directions in cerebrovascular disease management.

Historically, the field of cerebrovascular disease has undergone significant transformations. Advances in neuroimaging technologies and a better understanding of risk factors have revolutionized the diagnosis of CVD. The introduction of thrombolytic therapy and endovascular interventions has changed the landscape of acute stroke treatment, while ongoing research continues to refine management strategies for chronic cerebrovascular conditions. Despite these advancements, challenges remain in the early detection of CVD and effective treatment modalities, particularly in diverse populations. This Special Issue will trace the history of cerebrovascular disease management, highlighting key milestones and current gaps that require further exploration.

This Special Issue will feature cutting-edge research that highlights the latest breakthroughs in the diagnosis and treatment of cerebrovascular diseases. We aim to include studies that utilize novel imaging techniques, such as perfusion MRI and machine learning algorithms for stroke prediction, as well as research on emerging therapeutic agents that target the underlying mechanisms of cerebrovascular pathology. Additionally, we welcome investigations into multidisciplinary approaches that integrate medical, surgical, and rehabilitation strategies to optimize patient outcomes. By showcasing these advancements, we hope to foster collaboration and innovation in the field of cerebrovascular disease.

We invite original research articles, reviews, clinical guidelines, and case studies that contribute to the understanding and management of cerebrovascular disease. Specifically, we seek the following:

• Original research articles that present novel findings related to diagnostic techniques or treatment interventions;
• Comprehensive reviews that synthesize current knowledge and highlight gaps in the literature, offering insights into future research directions;
• Clinical guidelines or consensus statements that provide evidence-based recommendations for the diagnosis and management of cerebrovascular disease;
• Case studies that illustrate unique clinical presentations, innovative treatment approaches, or successful management strategies in cerebrovascular disease. Through this Special Issue, we aim to create a collaborative space for researchers, clinicians, and healthcare professionals to share knowledge and advance the field of cerebrovascular disease diagnosis and treatment.

You may choose choose our Joint Special Issue in Brain Sciences.

Dr. Marialuisa Zedde
Dr. Rosario Pascarella
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Neurology International is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• ischemic stroke
• SVD
• vasculitides
• fibromuscular dysplasia
• thrombolysis
• EVT
• plaque imaging
• intracranial stenosis